223 related articles for article (PubMed ID: 26713760)
21. Extra-basal ganglia iron content and non-motor symptoms in drug-naïve, early Parkinson's disease.
Kim M; Yoo S; Kim D; Cho JW; Kim JS; Ahn JH; Mun JK; Choi I; Lee SK; Youn J
Neurol Sci; 2021 Dec; 42(12):5297-5304. PubMed ID: 33860863
[TBL] [Abstract][Full Text] [Related]
22. Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature.
Péran P; Cherubini A; Assogna F; Piras F; Quattrocchi C; Peppe A; Celsis P; Rascol O; Démonet JF; Stefani A; Pierantozzi M; Pontieri FE; Caltagirone C; Spalletta G; Sabatini U
Brain; 2010 Nov; 133(11):3423-33. PubMed ID: 20736190
[TBL] [Abstract][Full Text] [Related]
23. Alterations of Diffusion Kurtosis and Neurite Density Measures in Deep Grey Matter and White Matter in Parkinson's Disease.
Surova Y; Lampinen B; Nilsson M; Lätt J; Hall S; Widner H; ; van Westen D; Hansson O
PLoS One; 2016; 11(6):e0157755. PubMed ID: 27362763
[TBL] [Abstract][Full Text] [Related]
24. Diffusion tensor imaging of nigral degeneration in Parkinson's disease: A region-of-interest and voxel-based study at 3 T and systematic review with meta-analysis.
Schwarz ST; Abaei M; Gontu V; Morgan PS; Bajaj N; Auer DP
Neuroimage Clin; 2013; 3():481-8. PubMed ID: 24273730
[TBL] [Abstract][Full Text] [Related]
25. Microstructural changes in the substantia nigra of asymptomatic agricultural workers.
Du G; Lewis MM; Sterling NW; Kong L; Chen H; Mailman RB; Huang X
Neurotoxicol Teratol; 2014; 41():60-4. PubMed ID: 24334261
[TBL] [Abstract][Full Text] [Related]
26. Diffusion tensor imaging of the substantia nigra in Parkinson's disease revisited.
Langley J; Huddleston DE; Merritt M; Chen X; McMurray R; Silver M; Factor SA; Hu X
Hum Brain Mapp; 2016 Jul; 37(7):2547-56. PubMed ID: 27029026
[TBL] [Abstract][Full Text] [Related]
27. MRI evaluation of the basal ganglia size and iron content in patients with Parkinson's disease.
Kosta P; Argyropoulou MI; Markoula S; Konitsiotis S
J Neurol; 2006 Jan; 253(1):26-32. PubMed ID: 15981079
[TBL] [Abstract][Full Text] [Related]
28. 3D texture analyses within the substantia nigra of Parkinson's disease patients on quantitative susceptibility maps and R2
Li G; Zhai G; Zhao X; An H; Spincemaille P; Gillen KM; Ku Y; Wang Y; Huang D; Li J
Neuroimage; 2019 Mar; 188():465-472. PubMed ID: 30578927
[TBL] [Abstract][Full Text] [Related]
29. High nigral iron deposition in LRRK2 and Parkin mutation carriers using R2* relaxometry.
Pyatigorskaya N; Sharman M; Corvol JC; Valabregue R; Yahia-Cherif L; Poupon F; Cormier-Dequaire F; Siebner H; Klebe S; Vidailhet M; Brice A; Lehéricy S
Mov Disord; 2015 Jul; 30(8):1077-84. PubMed ID: 26011561
[TBL] [Abstract][Full Text] [Related]
30. Substantia nigra fractional anisotropy is not a diagnostic biomarker of Parkinson's disease: A diagnostic performance study and meta-analysis.
Hirata FCC; Sato JR; Vieira G; Lucato LT; Leite CC; Bor-Seng-Shu E; Pastorello BF; Otaduy MCG; Chaim KT; Campanholo KR; Novaes NP; Melo LM; Gonçalves MR; do Nascimento FBP; Teixeira MJ; Barbosa ER; Amaro E; Cardoso EF
Eur Radiol; 2017 Jun; 27(6):2640-2648. PubMed ID: 27709279
[TBL] [Abstract][Full Text] [Related]
31. Region-specific disturbed iron distribution in early idiopathic Parkinson's disease measured by quantitative susceptibility mapping.
He N; Ling H; Ding B; Huang J; Zhang Y; Zhang Z; Liu C; Chen K; Yan F
Hum Brain Mapp; 2015 Nov; 36(11):4407-20. PubMed ID: 26249218
[TBL] [Abstract][Full Text] [Related]
32. Progressive microstructural alterations in subcortical nuclei in Parkinson's disease: A diffusion magnetic resonance imaging study.
Bai X; Zhou C; Guo T; Guan X; Wu J; Liu X; Gao T; Gu L; Xuan M; Gu Q; Huang P; Song Z; Yan Y; Pu J; Zhang B; Xu X; Zhang M
Parkinsonism Relat Disord; 2021 Jul; 88():82-89. PubMed ID: 34147950
[TBL] [Abstract][Full Text] [Related]
33. Magnetic resonance imaging-based volumetric analysis of basal ganglia nuclei and substantia nigra in patients with Parkinson's disease.
Geng DY; Li YX; Zee CS
Neurosurgery; 2006 Feb; 58(2):256-62; discussion 256-62. PubMed ID: 16462479
[TBL] [Abstract][Full Text] [Related]
34. Serum cholesterol and nigrostriatal R2* values in Parkinson's disease.
Du G; Lewis MM; Shaffer ML; Chen H; Yang QX; Mailman RB; Huang X
PLoS One; 2012; 7(4):e35397. PubMed ID: 22530017
[TBL] [Abstract][Full Text] [Related]
35. MRI assessment of basal ganglia iron deposition in Parkinson's disease.
Wallis LI; Paley MN; Graham JM; Grünewald RA; Wignall EL; Joy HM; Griffiths PD
J Magn Reson Imaging; 2008 Nov; 28(5):1061-7. PubMed ID: 18972346
[TBL] [Abstract][Full Text] [Related]
36. Fractional Anisotropy and Mean Diffusion as Measures of Dopaminergic Function in Parkinson's Disease: Challenging Results.
Lenfeldt N; Eriksson J; Åström B; Forsgren L; Mo SJ
J Parkinsons Dis; 2017; 7(1):129-142. PubMed ID: 28106567
[TBL] [Abstract][Full Text] [Related]
37. Correlation between relaxometry and diffusion tensor imaging in the globus pallidus of Huntington's disease patients.
Syka M; Keller J; Klempíř J; Rulseh AM; Roth J; Jech R; Vorisek I; Vymazal J
PLoS One; 2015; 10(3):e0118907. PubMed ID: 25781024
[TBL] [Abstract][Full Text] [Related]
38. [Parkinson's disease: diffusion kurtosis imaging and the correlation with clinical manifestations].
Sun YQ; Zhang Q; Jiang Z; Zhang CY; Zhang JW; Chen H; Shen JK
Zhonghua Yi Xue Za Zhi; 2017 Dec; 97(45):3534-3537. PubMed ID: 29275590
[No Abstract] [Full Text] [Related]
39. MRI diffusion in Parkinson's disease: using the technique's inherent directional information to study the olfactory bulb and substantia nigra.
Skorpil M; Söderlund V; Sundin A; Svenningsson P
J Parkinsons Dis; 2012; 2(2):171-80. PubMed ID: 23939442
[TBL] [Abstract][Full Text] [Related]
40. Diffusion tensor and restriction spectrum imaging reflect different aspects of neurodegeneration in Parkinson's disease.
Hope TR; Selnes P; Rektorová I; Anderkova L; Nemcova-Elfmarkova N; Balážová Z; Dale A; Bjørnerud A; Fladby T
PLoS One; 2019; 14(5):e0217922. PubMed ID: 31150514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
